Polymorphonuclear neutrophils (PMNs) are a type of white blood cell crucial to the immune system. Determining the proportion of these cells within a blood sample typically involves differential blood counts performed in hematology laboratories. The process often entails manual microscopic examination of a stained blood smear, where a trained technician identifies and counts different types of white blood cells, including PMNs. Alternatively, automated hematology analyzers can provide a complete blood count, including the percentage of neutrophils. For example, if a differential count of 100 white blood cells reveals that 60 are neutrophils, the percentage of neutrophils, representing the PMN proportion, is 60%. This percentage can be further considered alongside the total white blood cell count to calculate the absolute neutrophil count.
Accurately establishing the relative proportion of PMNs within the bloodstream is vital for diagnosing and monitoring a wide range of medical conditions. Elevated levels may indicate an infection, inflammation, or other physiological stress, while decreased levels can suggest immune deficiencies or bone marrow disorders. Historically, manual blood smear analysis was the only method available, a process that was time-consuming and prone to inter-observer variability. The advent of automated hematology analyzers has significantly improved the speed, accuracy, and standardization of cell counts, contributing to improved patient care and more efficient clinical workflows.